[
  {
    "title": "奥赛康(002755.SZ)：哌柏西利胶囊获准上市",
    "href": "http://stock.jrj.com.cn/2023/01/06165537264527.shtml",
    "datetime": "2023-01-06 16:55:33",
    "code": "002755"
  },
  {
    "title": "奥赛康：马来酸奈拉替尼片获得药品注册上市许可申请受理通知书",
    "href": "http://stock.jrj.com.cn/2022/11/20184437152520.shtml",
    "datetime": "2022-11-20 18:44:43",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)子公司马来酸奈拉替尼片获得药品注册上市许可申请受理通知书",
    "href": "http://stock.jrj.com.cn/2022/11/20165737152448.shtml",
    "datetime": "2022-11-20 16:57:13",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：中亿伟业减持到期已减持577.16万股 拟继续减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/11/03172537110136.shtml",
    "datetime": "2022-11-03 17:25:42",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)第三季度净亏损8073.95万元",
    "href": "http://stock.jrj.com.cn/2022/10/30181237097604.shtml",
    "datetime": "2022-10-30 18:12:44",
    "code": "002755"
  },
  {
    "title": "奥赛康涨停，马来酸奈拉替尼原料药上市登记获受理",
    "href": "http://stock.jrj.com.cn/2022/10/19120637066379.shtml",
    "datetime": "2022-10-19 12:06:53",
    "code": "002755"
  },
  {
    "title": "奥赛康披露2022年半年报，实现营收10.11亿元",
    "href": "http://stock.jrj.com.cn/2022/08/29163836947499.shtml",
    "datetime": "2022-08-29 16:38:01",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)半年度净利润1249.60万元、同比下降95.25%",
    "href": "http://stock.jrj.com.cn/2022/08/28180736944475.shtml",
    "datetime": "2022-08-28 18:07:18",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：奥赛康生物的生物创新药注射用ASKG315获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/08/19210336918020.shtml",
    "datetime": "2022-08-19 21:03:50",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用福沙匹坦双葡甲胺上市申请获受理",
    "href": "http://stock.jrj.com.cn/2022/08/09171736883238.shtml",
    "datetime": "2022-08-09 17:17:11",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：上半年净利预降94.30%-96.20%",
    "href": "http://stock.jrj.com.cn/2022/07/14175736811974.shtml",
    "datetime": "2022-07-14 17:57:48",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：4项产品参与全国药品集中采购拟中标",
    "href": "http://stock.jrj.com.cn/2022/07/13175636808024.shtml",
    "datetime": "2022-07-13 17:56:30",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司获授权推广艾司奥美拉唑镁肠溶干混悬剂",
    "href": "http://stock.jrj.com.cn/2022/07/11173436799436.shtml",
    "datetime": "2022-07-11 17:34:57",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用硫酸艾沙康唑上市申请获受理",
    "href": "http://stock.jrj.com.cn/2022/07/05180136784212.shtml",
    "datetime": "2022-07-05 18:01:01",
    "code": "002755"
  },
  {
    "title": "奥赛康单方推收购唯德康60%股权告吹 业绩陷低迷一季度净利降89.14%",
    "href": "http://stock.jrj.com.cn/2022/06/23111036752370.shtml",
    "datetime": "2022-06-23 11:10:05",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：终止发行股份及支付现金购买江苏唯德康医疗60%的股权",
    "href": "http://stock.jrj.com.cn/2022/06/19160436740559.shtml",
    "datetime": "2022-06-19 16:04:27",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：减持期过半、中亿伟业已减持45.0603万股",
    "href": "http://stock.jrj.com.cn/2022/06/10173236719790.shtml",
    "datetime": "2022-06-10 17:32:57",
    "code": "002755"
  },
  {
    "title": "A股异动丨奥赛康涨停 子公司新药ASK120067片在2022 ASCO年会展示临床数据",
    "href": "http://stock.jrj.com.cn/2022/06/08104736711588.shtml",
    "datetime": "2022-06-08 10:47:03",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司新药ASK120067片在2022 ASCO年会展示临床数据",
    "href": "http://stock.jrj.com.cn/2022/06/07175536709760.shtml",
    "datetime": "2022-06-07 17:55:41",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用ASK0912获批开展临床试验",
    "href": "http://stock.jrj.com.cn/2022/05/30180536690321.shtml",
    "datetime": "2022-05-30 18:05:12",
    "code": "002755"
  },
  {
    "title": "奥赛康交易中场“夭折”，集采压力下如何解困？",
    "href": "http://stock.jrj.com.cn/2022/04/19062536392507.shtml",
    "datetime": "2022-04-19 06:25:30",
    "code": "002755"
  },
  {
    "title": "奥赛康收购唯德康医疗再生变数，交易对方拟单方面终止交易",
    "href": "http://stock.jrj.com.cn/2022/04/18082836378280.shtml",
    "datetime": "2022-04-18 08:28:15",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：就收购唯德康医疗60%股权 交易对方单方面要求终止交易协议",
    "href": "http://stock.jrj.com.cn/2022/04/17174636368950.shtml",
    "datetime": "2022-04-17 17:46:12",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)旗下AskGene获启明等2000万美元投资",
    "href": "http://stock.jrj.com.cn/2022/03/21182034856738.shtml",
    "datetime": "2022-03-21 18:20:02",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：中亿伟业拟减持不超928万股",
    "href": "http://stock.jrj.com.cn/2022/03/18192834846727.shtml",
    "datetime": "2022-03-18 19:28:29",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用ASK0912新药临床试验申请获受理",
    "href": "http://stock.jrj.com.cn/2022/03/15183334830247.shtml",
    "datetime": "2022-03-15 18:33:05",
    "code": "002755"
  },
  {
    "title": "奥赛康选举陈庆财为董事长 2021年第三季度公司净利1.29亿",
    "href": "http://stock.jrj.com.cn/2022/02/18215034400392.shtml",
    "datetime": "2022-02-18 21:50:37",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司新药ASKC202片获批临床试验",
    "href": "http://stock.jrj.com.cn/2022/02/15170334354141.shtml",
    "datetime": "2022-02-15 17:03:31",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司盐酸左布比卡因注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/25191234213510.shtml",
    "datetime": "2022-01-25 19:12:46",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：约5.74亿股限售股1月25日解禁",
    "href": "http://stock.jrj.com.cn/2022/01/23205234194914.shtml",
    "datetime": "2022-01-23 20:52:17",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司ASKG712注射液获得临床试验批准通知书",
    "href": "http://stock.jrj.com.cn/2022/01/17185334165716.shtml",
    "datetime": "2022-01-17 18:53:26",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用替加环素通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/24171434058292.shtml",
    "datetime": "2021-12-24 17:14:29",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司新药ASKC202片获得临床试验申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/12/05184633965634.shtml",
    "datetime": "2021-12-05 18:46:07",
    "code": "002755"
  },
  {
    "title": "奥赛康：新药ASKC202片获临床试验申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/12/05164133965294.shtml",
    "datetime": "2021-12-05 16:41:59",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：艾司奥美拉唑镁肠溶干混悬剂上市申请获受理",
    "href": "http://stock.jrj.com.cn/2021/12/01202833951450.shtml",
    "datetime": "2021-12-01 20:28:20",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用右雷佐生通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/01202433951436.shtml",
    "datetime": "2021-12-01 20:24:07",
    "code": "002755"
  },
  {
    "title": "奥赛康：子公司替莫唑胺胶囊上市申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/26165433923960.shtml",
    "datetime": "2021-11-26 16:54:54",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：继续推进发行股份及支付现金购买资产事项",
    "href": "http://stock.jrj.com.cn/2021/11/19202933881947.shtml",
    "datetime": "2021-11-19 20:29:28",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：恩格列净片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/11/19202833881945.shtml",
    "datetime": "2021-11-19 20:28:00",
    "code": "002755"
  },
  {
    "title": "A股异动 | 奥赛康盘中涨9% 子公司ASK120067片上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/17093933864503.shtml",
    "datetime": "2021-11-17 09:39:15",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司ASK120067片上市许可申请获受理",
    "href": "http://stock.jrj.com.cn/2021/11/16170633860715.shtml",
    "datetime": "2021-11-16 17:06:22",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：收到中证监不予核准公司发行股份购买资产申请的决定",
    "href": "http://stock.jrj.com.cn/2021/11/15213233856212.shtml",
    "datetime": "2021-11-15 21:32:27",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用奈达铂通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/11/08205933824529.shtml",
    "datetime": "2021-11-08 20:59:42",
    "code": "002755"
  },
  {
    "title": "奥赛康：前三季度净利润3.92亿元，同比下降18.21%",
    "href": "http://stock.jrj.com.cn/2021/10/30205433783455.shtml",
    "datetime": "2021-10-30 20:54:48",
    "code": "002755"
  },
  {
    "title": "溢价6倍收购被否，消化龙头一字跌停",
    "href": "http://stock.jrj.com.cn/2021/10/28162733769302.shtml",
    "datetime": "2021-10-28 16:27:25",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：资产重组事项10月27日上会 当日停牌",
    "href": "http://stock.jrj.com.cn/2021/10/21195933729027.shtml",
    "datetime": "2021-10-21 19:59:05",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用多黏菌素E甲磺酸钠获得药品注册批准",
    "href": "http://stock.jrj.com.cn/2021/10/21194633728943.shtml",
    "datetime": "2021-10-21 19:46:35",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用唑来膦酸浓溶液上市申请获受理",
    "href": "http://stock.jrj.com.cn/2021/10/21194333728930.shtml",
    "datetime": "2021-10-21 19:43:56",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：资产重组事项近日上会 当日停牌",
    "href": "http://stock.jrj.com.cn/2021/10/20204633723481.shtml",
    "datetime": "2021-10-20 20:46:27",
    "code": "002755"
  },
  {
    "title": "奥赛康聘任马竞飞为公司副总经理 上半年公司净利2.63亿",
    "href": "http://stock.jrj.com.cn/2021/10/08220033659639.shtml",
    "datetime": "2021-10-08 22:00:23",
    "code": "002755"
  },
  {
    "title": "奥赛康2021年半年度净利2.63亿元 同比净利增加15.39%",
    "href": "http://stock.jrj.com.cn/2021/08/29193633341272.shtml",
    "datetime": "2021-08-29 19:36:33",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)半年度净利润2.63亿元 同比增长15.39%",
    "href": "http://stock.jrj.com.cn/2021/08/29172033340774.shtml",
    "datetime": "2021-08-29 17:20:18",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：资产重组申请获中证监受理",
    "href": "http://stock.jrj.com.cn/2021/08/10193533233254.shtml",
    "datetime": "2021-08-10 19:35:40",
    "code": "002755"
  },
  {
    "title": "奥赛康溢价6倍收购资产，造两名亿万富翁",
    "href": "http://stock.jrj.com.cn/2021/07/15090833100182.shtml",
    "datetime": "2021-07-15 09:08:00",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：ASKC852片获批临床试验",
    "href": "http://stock.jrj.com.cn/2021/06/28174933010893.shtml",
    "datetime": "2021-06-28 17:49:09",
    "code": "002755"
  },
  {
    "title": "奥赛康：积极探索与主营业务具有产业协同性的战略投资并购机会",
    "href": "http://stock.jrj.com.cn/2021/06/23133132982377.shtml",
    "datetime": "2021-06-23 13:31:41",
    "code": "002755"
  },
  {
    "title": "奥赛康：发行股份及支付现金购买资产事项正在进行中半年度报告暂不并表",
    "href": "http://stock.jrj.com.cn/2021/06/23133132982374.shtml",
    "datetime": "2021-06-23 13:31:39",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司将利用产品群优势、原料制剂一体化优势和申报一致性评价的先发优势积极应对集采",
    "href": "http://stock.jrj.com.cn/2021/06/23133132982375.shtml",
    "datetime": "2021-06-23 13:31:29",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司子公司Askgene与Xilio签订的《专利授权许可协议》将加快公司在肿瘤免疫领域的研发管线布局",
    "href": "http://stock.jrj.com.cn/2021/06/22230132979495.shtml",
    "datetime": "2021-06-22 23:01:35",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：地拉罗司分散片获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/22171632976878.shtml",
    "datetime": "2021-06-22 17:16:03",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用达托霉素(0.35g)获批上市",
    "href": "http://stock.jrj.com.cn/2021/06/21174432970392.shtml",
    "datetime": "2021-06-21 17:44:01",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)2020年度权益分派10派2元 股权登记日为6月17日",
    "href": "http://stock.jrj.com.cn/2021/06/09201932901202.shtml",
    "datetime": "2021-06-09 20:19:05",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司大股东认可公司价值 目前无减持计划",
    "href": "http://stock.jrj.com.cn/2021/06/02225332865857.shtml",
    "datetime": "2021-06-02 22:53:06",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司本次增发购买资产行为不存在利益输送的情形",
    "href": "http://stock.jrj.com.cn/2021/06/02225232865856.shtml",
    "datetime": "2021-06-02 22:52:04",
    "code": "002755"
  },
  {
    "title": "奥赛康：目前公司泊沙康唑产品未在海外销售",
    "href": "http://stock.jrj.com.cn/2021/06/02225132865855.shtml",
    "datetime": "2021-06-02 22:51:39",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司抗真菌药物泊沙康唑对毛霉菌有较好抗菌活性",
    "href": "http://stock.jrj.com.cn/2021/06/02225132865849.shtml",
    "datetime": "2021-06-02 22:51:20",
    "code": "002755"
  },
  {
    "title": "奥赛康：若股权收购交易对方业绩不达标 将向上市公司进行补偿",
    "href": "http://stock.jrj.com.cn/2021/06/02225032865847.shtml",
    "datetime": "2021-06-02 22:50:15",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司未发生过环境污染事故 也未受到过相关处罚",
    "href": "http://stock.jrj.com.cn/2021/06/02224932865848.shtml",
    "datetime": "2021-06-02 22:49:43",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：约1.8141亿股限售股将解禁",
    "href": "http://stock.jrj.com.cn/2021/05/27181532831001.shtml",
    "datetime": "2021-05-27 18:15:14",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用地西他滨通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/26195232824867.shtml",
    "datetime": "2021-05-26 19:52:48",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：多西他赛注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/05/11222632737864.shtml",
    "datetime": "2021-05-11 22:26:31",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司泊沙康唑注射液获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/05/06200732703090.shtml",
    "datetime": "2021-05-06 20:07:00",
    "code": "002755"
  },
  {
    "title": "奥赛康溢价11倍收购涉嫌利益输送 停牌筹划前标的公司密集增资重组",
    "href": "http://stock.jrj.com.cn/2021/04/27071832461074.shtml",
    "datetime": "2021-04-27 07:18:20",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：拟以8.34亿元收购唯德康医疗60%股权 4月26日复牌",
    "href": "http://stock.jrj.com.cn/2021/04/25223432440246.shtml",
    "datetime": "2021-04-25 22:34:42",
    "code": "002755"
  },
  {
    "title": "奥赛康：拟8.34亿元购买唯德康医疗60%股权",
    "href": "http://stock.jrj.com.cn/2021/04/25161732437828.shtml",
    "datetime": "2021-04-25 16:17:06",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：正筹划收购江苏唯德康医疗60%股权 明起停牌",
    "href": "http://stock.jrj.com.cn/2021/04/13180632366084.shtml",
    "datetime": "2021-04-13 18:06:30",
    "code": "002755"
  },
  {
    "title": "奥赛康2021年第一季度预计净利1.76亿-1.83亿增长65%-72%",
    "href": "http://stock.jrj.com.cn/2021/03/30093632246233.shtml",
    "datetime": "2021-03-30 09:36:53",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：麦芽酚铁胶囊已获临床试验批准",
    "href": "http://stock.jrj.com.cn/2021/03/29210932243312.shtml",
    "datetime": "2021-03-29 21:09:33",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)一季度净利润预增64.76%-72.09%",
    "href": "http://stock.jrj.com.cn/2021/03/29203832243114.shtml",
    "datetime": "2021-03-29 20:38:03",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用右雷佐生获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/03/18194932158915.shtml",
    "datetime": "2021-03-18 19:49:03",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：与上海药明康德合作开发新药并签署合作开发合同书",
    "href": "http://stock.jrj.com.cn/2021/03/18172432158014.shtml",
    "datetime": "2021-03-18 17:24:16",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司盐酸帕洛诺司琼注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/15201832138736.shtml",
    "datetime": "2021-03-15 20:18:37",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用培美曲塞二钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/12082832113290.shtml",
    "datetime": "2021-03-12 08:28:10",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：哌柏西利胶囊获得上市许可申请受理通知书",
    "href": "http://stock.jrj.com.cn/2021/03/01201932052350.shtml",
    "datetime": "2021-03-01 20:19:59",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：赛瑞替尼胶囊新药上市申请获受理",
    "href": "http://stock.jrj.com.cn/2021/02/25201332027645.shtml",
    "datetime": "2021-02-25 20:13:38",
    "code": "002755"
  },
  {
    "title": "奥赛康：和Xilio Therapeutics合作将加快公司在肿瘤免疫领域的研发管线布局",
    "href": "http://stock.jrj.com.cn/2021/02/25080332022931.shtml",
    "datetime": "2021-02-25 08:03:19",
    "code": "002755"
  },
  {
    "title": "奥赛康：目前未涉及禽流感病毒相关药品",
    "href": "http://stock.jrj.com.cn/2021/02/25080332022930.shtml",
    "datetime": "2021-02-25 08:03:01",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司将自研平台Smartkine部分专利授权Xilio",
    "href": "http://stock.jrj.com.cn/2021/02/19083931990647.shtml",
    "datetime": "2021-02-19 08:39:51",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)业绩快报：2020年度净利润降6.87%至7.27亿元",
    "href": "http://stock.jrj.com.cn/2021/02/18143131985894.shtml",
    "datetime": "2021-02-18 14:31:52",
    "code": "002755"
  },
  {
    "title": "疫情影响，奥赛康2020年归属于股东净利润同比下降6.87%",
    "href": "http://stock.jrj.com.cn/2021/02/18135031985690.shtml",
    "datetime": "2021-02-18 13:50:19",
    "code": "002755"
  },
  {
    "title": "奥赛康2020年度净利7.27亿下滑6.87% 产品销售下降幅度较大",
    "href": "http://stock.jrj.com.cn/2021/02/18101231984689.shtml",
    "datetime": "2021-02-18 10:12:43",
    "code": "002755"
  },
  {
    "title": "奥赛康2020年净利7.27亿同比下降6.9%：布局肿瘤免疫领域生物创新药",
    "href": "http://stock.jrj.com.cn/2021/02/18083731984206.shtml",
    "datetime": "2021-02-18 08:37:48",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康产品注射用替莫唑胺成功获批上市",
    "href": "http://stock.jrj.com.cn/2021/01/19000031744030.shtml",
    "datetime": "2021-01-19 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用替莫唑胺获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2021/01/18204431717078.shtml",
    "datetime": "2021-01-18 20:44:39",
    "code": "002755"
  },
  {
    "title": "奥赛康：注射用艾司奥美拉唑钠通过仿制药一致性评价 有利于进一步增强该药品技术优势",
    "href": "http://stock.jrj.com.cn/2021/01/13142631683747.shtml",
    "datetime": "2021-01-13 14:26:27",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用艾司奥美拉唑钠通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/13081731680883.shtml",
    "datetime": "2021-01-13 08:17:22",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康PPI注射剂产品奥一明——注射用艾司奥美拉唑钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/13000031688295.shtml",
    "datetime": "2021-01-13 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康PPI产品——2类新药注射用右兰索拉唑上市申请获得受理",
    "href": "http://stock.jrj.com.cn/2021/01/12000031681023.shtml",
    "datetime": "2021-01-12 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司以新4类申报的甲磺酸仑伐替尼胶囊上市申请于2020年3月获得CDE承办受理 目前处于CDE审评审批中",
    "href": "http://stock.jrj.com.cn/2021/01/07120131647023.shtml",
    "datetime": "2021-01-07 12:01:06",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：注射用奥美拉唑钠首家通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/01/05202831636388.shtml",
    "datetime": "2021-01-05 20:28:24",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司将利用上市公司平台不断寻求优质资产并购机会 提升公司价值",
    "href": "http://stock.jrj.com.cn/2021/01/05080631631702.shtml",
    "datetime": "2021-01-05 08:06:24",
    "code": "002755"
  },
  {
    "title": "奥赛康：目前已开展的三批国家集采未涉及公司在售PPI产品",
    "href": "http://stock.jrj.com.cn/2021/01/05080331631697.shtml",
    "datetime": "2021-01-05 08:03:06",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)子公司注射用帕瑞昔布钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/29221231597890.shtml",
    "datetime": "2020-12-29 22:12:38",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司在售产品中除个别产品外 均已在国家医保目录中",
    "href": "http://stock.jrj.com.cn/2020/12/21082931532658.shtml",
    "datetime": "2020-12-21 08:29:16",
    "code": "002755"
  },
  {
    "title": "奥赛康：AskGene专注于大分子生物创新药的研发",
    "href": "http://stock.jrj.com.cn/2020/12/21082931532657.shtml",
    "datetime": "2020-12-21 08:29:04",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康产品欧丽——盐酸帕洛诺司琼注射液获批新规格",
    "href": "http://stock.jrj.com.cn/2020/12/08000031561815.shtml",
    "datetime": "2020-12-08 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：盐酸帕洛诺司琼注射液获得补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2020/12/07195431432633.shtml",
    "datetime": "2020-12-07 19:54:44",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司积极参与多个集采项目如山东、武汉、安徽、重庆联盟等",
    "href": "http://stock.jrj.com.cn/2020/12/04080431404923.shtml",
    "datetime": "2020-12-04 08:04:34",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用兰索拉唑首家通过一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/04075431405019.shtml",
    "datetime": "2020-12-04 07:54:38",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康PPI注射剂产品奥维加——注射用兰索拉唑首家通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/12/04000031561813.shtml",
    "datetime": "2020-12-04 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康再次荣获“生物医药产业最具成长上市公司”",
    "href": "http://stock.jrj.com.cn/2020/11/28000031561811.shtml",
    "datetime": "2020-11-28 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康荣获2019年度金牛“最具投资价值奖”",
    "href": "http://stock.jrj.com.cn/2020/11/20000031561810.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康子公司海润医药再度入选南京江北新区“灵雀计划”企业名单",
    "href": "http://stock.jrj.com.cn/2020/11/20000031561812.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：公司引进的创新药ASKC109口服铁剂项目拟于今年年内申报IND",
    "href": "http://stock.jrj.com.cn/2020/11/16132931291513.shtml",
    "datetime": "2020-11-16 13:29:55",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康举办“全国消防日”系列主题活动",
    "href": "http://stock.jrj.com.cn/2020/11/09000031561809.shtml",
    "datetime": "2020-11-09 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康PPI产品潘美路——注射用泮托拉唑钠首家通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/11/03000031561807.shtml",
    "datetime": "2020-11-03 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司获得苹果酸卡博替尼片上市申请受理通知书",
    "href": "http://stock.jrj.com.cn/2020/11/02204531202835.shtml",
    "datetime": "2020-11-02 20:45:32",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)：子公司注射用泮托拉唑钠首家通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2020/11/02204431202836.shtml",
    "datetime": "2020-11-02 20:44:47",
    "code": "002755"
  },
  {
    "title": "奥赛康2020年前三季度净利4.79亿下滑18.24% 财务费用增长",
    "href": "http://stock.jrj.com.cn/2020/10/26113031131925.shtml",
    "datetime": "2020-10-26 11:30:14",
    "code": "002755"
  },
  {
    "title": "奥赛康(002755.SZ)第三季度净利润升23.13%至2.51亿元",
    "href": "http://stock.jrj.com.cn/2020/10/25171331123252.shtml",
    "datetime": "2020-10-25 17:13:17",
    "code": "002755"
  },
  {
    "title": "奥赛康：前三季度净利润同比减少18.24%",
    "href": "http://stock.jrj.com.cn/2020/10/25161631123120.shtml",
    "datetime": "2020-10-25 16:16:57",
    "code": "002755"
  },
  {
    "title": "[奥赛康]夯实细分领域品牌影响力,化学制药行业排名创新高——奥赛康收获多项殊荣",
    "href": "http://stock.jrj.com.cn/2020/10/13000031561843.shtml",
    "datetime": "2020-10-13 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业成功承办江苏省高价值专利培育计划项目示范会",
    "href": "http://stock.jrj.com.cn/2020/09/19000031561845.shtml",
    "datetime": "2020-09-19 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康举办“ASK研究院实验室管理条例试行启动会”",
    "href": "http://stock.jrj.com.cn/2020/09/02000031561846.shtml",
    "datetime": "2020-09-02 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康2020年上半年净利2.28亿下滑40.32% 大量医院关闭非疫情住院部",
    "href": "http://stock.jrj.com.cn/2020/08/25222030588282.shtml",
    "datetime": "2020-08-25 22:20:06",
    "code": "002755"
  },
  {
    "title": "奥赛康子公司涉行贿案 去年营收45亿元销售费用28亿",
    "href": "http://stock.jrj.com.cn/2020/07/07180130169060.shtml",
    "datetime": "2020-07-07 18:01:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]创新驱动丨奥赛康连续四年入选“2019江苏省百强创新型企业”",
    "href": "http://stock.jrj.com.cn/2020/07/03000031561837.shtml",
    "datetime": "2020-07-03 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康与南京医科大学签订战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/06/28000031561841.shtml",
    "datetime": "2020-06-28 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康举办急救知识培训",
    "href": "http://stock.jrj.com.cn/2020/06/24000031561838.shtml",
    "datetime": "2020-06-24 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]江苏省政府研究室专题评估团队一行莅临奥赛康调研指导",
    "href": "http://stock.jrj.com.cn/2020/06/19000031561847.shtml",
    "datetime": "2020-06-19 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]财政部江苏监管局一行莅临奥赛康调研指导",
    "href": "http://stock.jrj.com.cn/2020/06/18000031561850.shtml",
    "datetime": "2020-06-18 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：注射用格列本脲通过临床试验申请",
    "href": "http://stock.jrj.com.cn/2020/06/16195729940294.shtml",
    "datetime": "2020-06-16 19:57:04",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业荣获省、市、区工会颁发的多项荣誉",
    "href": "http://stock.jrj.com.cn/2020/06/05000031561857.shtml",
    "datetime": "2020-06-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]南京市委常委、政法委书记徐锦辉一行莅临奥赛康调研指导",
    "href": "http://stock.jrj.com.cn/2020/06/04000031561818.shtml",
    "datetime": "2020-06-04 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康2019年净利7.81亿增长16.55% 董事长薪酬189万",
    "href": "http://stock.jrj.com.cn/2020/05/02114829458534.shtml",
    "datetime": "2020-05-02 11:48:19",
    "code": "002755"
  },
  {
    "title": "奥赛康2020年第一季度净利1.07亿下滑43.35% 销售收入减少所致",
    "href": "http://stock.jrj.com.cn/2020/05/02102429457182.shtml",
    "datetime": "2020-05-02 10:24:24",
    "code": "002755"
  },
  {
    "title": "奥赛康1800万新研药获注册受理 借壳上市后主营产品迎来新增长",
    "href": "http://stock.jrj.com.cn/2020/03/06080528965155.shtml",
    "datetime": "2020-03-06 08:05:00",
    "code": "002755"
  },
  {
    "title": "奥赛康2019年净利7.93亿增长18% 相关药品销售持续增长",
    "href": "http://stock.jrj.com.cn/2020/02/26173328898164.shtml",
    "datetime": "2020-02-26 17:33:48",
    "code": "002755"
  },
  {
    "title": "奥赛康：子公司3600万元对外投资",
    "href": "http://stock.jrj.com.cn/2020/02/13212728825745.shtml",
    "datetime": "2020-02-13 21:27:46",
    "code": "002755"
  },
  {
    "title": "奥赛康：拟3600万元增资入股贵科药业",
    "href": "http://stock.jrj.com.cn/2020/02/13185628824888.shtml",
    "datetime": "2020-02-13 18:56:24",
    "code": "002755"
  },
  {
    "title": "奥赛康：江苏奥赛康拟3600万元增资贵科药业 获其33.96%股权",
    "href": "http://stock.jrj.com.cn/2020/02/13173928824368.shtml",
    "datetime": "2020-02-13 17:39:01",
    "code": "002755"
  },
  {
    "title": "[奥赛康]复工第一天:“防疫”“生产”双保障",
    "href": "http://stock.jrj.com.cn/2020/02/10000031561821.shtml",
    "datetime": "2020-02-10 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：捐献100万现金用于疫区急需物资购买",
    "href": "http://stock.jrj.com.cn/2020/01/29225828741962.shtml",
    "datetime": "2020-01-29 22:58:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康参加江宁高新区迎新春登山乐跑活动",
    "href": "http://stock.jrj.com.cn/2020/01/19000031561819.shtml",
    "datetime": "2020-01-19 00:00:00",
    "code": "002755"
  },
  {
    "title": "早间公告：奥赛康子公司引进英国Shield Therapeutics公司产品",
    "href": "http://stock.jrj.com.cn/2020/01/08081928641141.shtml",
    "datetime": "2020-01-08 08:19:10",
    "code": "002755"
  },
  {
    "title": "早间公告：奥赛康子公司引进英国Shield Therapeutics公司产品",
    "href": "http://stock.jrj.com.cn/2020/01/08081428641138.shtml",
    "datetime": "2020-01-08 08:14:00",
    "code": "002755"
  },
  {
    "title": "泊沙康唑肠溶片预计2020年国内上市 奥赛康子公司获中国大陆独家代理权",
    "href": "http://stock.jrj.com.cn/2019/12/13211628531864.shtml",
    "datetime": "2019-12-13 21:16:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：子公司拟独家代理泊沙康唑肠溶片中国大陆地区销售权",
    "href": "http://stock.jrj.com.cn/2019/12/13190528531459.shtml",
    "datetime": "2019-12-13 19:05:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：子公司签署独家代理合作意向书",
    "href": "http://stock.jrj.com.cn/2019/12/13180928530857.shtml",
    "datetime": "2019-12-13 18:09:27",
    "code": "002755"
  },
  {
    "title": "奥赛康：此次医保目录谈判未有公司品种涉及",
    "href": "http://stock.jrj.com.cn/2019/12/02092628475798.shtml",
    "datetime": "2019-12-02 09:26:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康连续八年入榜中国创新力医药企业榜单",
    "href": "http://stock.jrj.com.cn/2019/11/17000031561831.shtml",
    "datetime": "2019-11-17 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]最成长、好口碑!奥赛康荣登“最具成长性大健康产业上市公司”口碑榜",
    "href": "http://stock.jrj.com.cn/2019/11/09000031561856.shtml",
    "datetime": "2019-11-09 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康被国家工信部认定为“国家技术创新示范企业”",
    "href": "http://stock.jrj.com.cn/2019/11/08000031561825.shtml",
    "datetime": "2019-11-08 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康第三季度盈利12.35亿 同比增长23%",
    "href": "http://stock.jrj.com.cn/2019/10/24222028296606.shtml",
    "datetime": "2019-10-24 22:20:23",
    "code": "002755"
  },
  {
    "title": "奥赛康：江苏子公司签订技术开发合同 将参与开发一类创新药项目",
    "href": "http://stock.jrj.com.cn/2019/10/17174028262361.shtml",
    "datetime": "2019-10-17 17:40:31",
    "code": "002755"
  },
  {
    "title": "奥赛康子公司签署技术开发合同",
    "href": "http://stock.jrj.com.cn/2019/10/17171728262253.shtml",
    "datetime": "2019-10-17 17:17:05",
    "code": "002755"
  },
  {
    "title": "奥赛康：子公司签署技术开发合同",
    "href": "http://stock.jrj.com.cn/2019/10/17170128262201.shtml",
    "datetime": "2019-10-17 17:01:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]献礼新中国70华诞,奥赛康药业再获两项殊荣!",
    "href": "http://stock.jrj.com.cn/2019/10/12000031561835.shtml",
    "datetime": "2019-10-12 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]2019中国化学制药行业年度峰会奥赛康收获多项荣誉!",
    "href": "http://stock.jrj.com.cn/2019/10/11000031561834.shtml",
    "datetime": "2019-10-11 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康入选南京市第一批环保信任保护企业名单",
    "href": "http://stock.jrj.com.cn/2019/09/05000031561852.shtml",
    "datetime": "2019-09-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业入选 “亚太地区最具创新力制药企业”榜单",
    "href": "http://stock.jrj.com.cn/2019/08/30000031561848.shtml",
    "datetime": "2019-08-30 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]突破!2018年度“中国医药工业百强企业榜单”发布,奥赛康排名创新高!",
    "href": "http://stock.jrj.com.cn/2019/08/26000031561849.shtml",
    "datetime": "2019-08-26 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]新医改十年,强研发时代——奥赛康连续十年入选中国医药工业研发产品线最佳工业企业",
    "href": "http://stock.jrj.com.cn/2019/08/26000031561823.shtml",
    "datetime": "2019-08-26 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：终止非公开发行股票事项",
    "href": "http://stock.jrj.com.cn/2019/08/21212628012759.shtml",
    "datetime": "2019-08-21 21:26:42",
    "code": "002755"
  },
  {
    "title": "奥赛康2019年上半年净利润3.82亿元 部分新品有望明年申请上市",
    "href": "http://stock.jrj.com.cn/2019/08/21202228012542.shtml",
    "datetime": "2019-08-21 20:22:00",
    "code": "002755"
  },
  {
    "title": "奥赛康上半年净利润同比增长18% 终止10.5亿元定增方案",
    "href": "http://stock.jrj.com.cn/2019/08/21201528012495.shtml",
    "datetime": "2019-08-21 20:15:46",
    "code": "002755"
  },
  {
    "title": "奥赛康：上半年净利润同比增长18% 终止10.5亿元定增方案",
    "href": "http://stock.jrj.com.cn/2019/08/21193628012346.shtml",
    "datetime": "2019-08-21 19:36:00",
    "code": "002755"
  },
  {
    "title": "奥赛康2019年上半年净利3.82亿 先后荣获中国专利金奖",
    "href": "http://stock.jrj.com.cn/2019/08/21184428012135.shtml",
    "datetime": "2019-08-21 18:44:38",
    "code": "002755"
  },
  {
    "title": "[奥赛康]为奥赛康质量月打CALL 丨视频纠错大赛成功举办",
    "href": "http://stock.jrj.com.cn/2019/08/21000031561822.shtml",
    "datetime": "2019-08-21 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]五项激励丨奥赛康奖学金颁发仪式成功举办",
    "href": "http://stock.jrj.com.cn/2019/08/20000031561824.shtml",
    "datetime": "2019-08-20 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业锚定高质量发展 入选“中小板上市公司价值50强”",
    "href": "http://stock.jrj.com.cn/2019/08/12000031561826.shtml",
    "datetime": "2019-08-12 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康质量月主题活动之——无菌更衣技能大赛",
    "href": "http://stock.jrj.com.cn/2019/08/05000031561851.shtml",
    "datetime": "2019-08-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康质量月主题活动之——灯检技能大赛",
    "href": "http://stock.jrj.com.cn/2019/07/28000031561833.shtml",
    "datetime": "2019-07-28 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]工匠精神丨奥赛康参加2019年全国QC成果发表会",
    "href": "http://stock.jrj.com.cn/2019/07/25000031561830.shtml",
    "datetime": "2019-07-25 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]江苏省产业技术研究院-奥赛康联合创新中心正式成立",
    "href": "http://stock.jrj.com.cn/2019/06/13000031561854.shtml",
    "datetime": "2019-06-13 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]安全生产月丨 消防应急演练活动成功举办",
    "href": "http://stock.jrj.com.cn/2019/06/13000031561832.shtml",
    "datetime": "2019-06-13 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康：子公司获得两份《药品GMP证书》",
    "href": "http://stock.jrj.com.cn/2019/06/12183427695419.shtml",
    "datetime": "2019-06-12 18:34:31",
    "code": "002755"
  },
  {
    "title": "奥赛康学术推广费超24亿 264名销售员每天花费近3万",
    "href": "http://stock.jrj.com.cn/2019/06/10074227679129.shtml",
    "datetime": "2019-06-10 07:42:51",
    "code": "002755"
  },
  {
    "title": "[奥赛康]安全生产月丨室外安全综合竞赛活动顺利举办!",
    "href": "http://stock.jrj.com.cn/2019/06/10000031561829.shtml",
    "datetime": "2019-06-10 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]世界环境日丨美丽奥赛康,我是行动者!",
    "href": "http://stock.jrj.com.cn/2019/06/07000031561855.shtml",
    "datetime": "2019-06-07 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]安全生产月|公司邀请红十字会专业人士开展急救知识培训",
    "href": "http://stock.jrj.com.cn/2019/06/02000031561820.shtml",
    "datetime": "2019-06-02 00:00:00",
    "code": "002755"
  },
  {
    "title": "奥赛康子公司被诉侵害发明专利 法院已受理相关诉讼",
    "href": "http://stock.jrj.com.cn/invest/2019/05/10171827571422.shtml",
    "datetime": "2019-05-10 17:18:00",
    "code": "002755"
  },
  {
    "title": "奥赛康子公司被诉侵害发明专利 法院已受理相关诉讼",
    "href": "http://stock.jrj.com.cn/invest/2019/05/10171827554884.shtml",
    "datetime": "2019-05-10 17:18:00",
    "code": "002755"
  },
  {
    "title": "奥赛康子公司被诉侵害发明专利 法院已受理相关诉讼",
    "href": "http://stock.jrj.com.cn/invest/2019/05/10171827568160.shtml",
    "datetime": "2019-05-10 17:18:00",
    "code": "002755"
  },
  {
    "title": "奥赛康一季度净利1.88亿同比增长18% 现金流量净额3781万",
    "href": "http://stock.jrj.com.cn/2019/05/06062127526619.shtml",
    "datetime": "2019-05-06 06:21:11",
    "code": "002755"
  },
  {
    "title": "奥赛康去年营收39亿元 同比增长15% 原董事长陈会利薪酬36万元",
    "href": "http://stock.jrj.com.cn/2019/05/05084427522846.shtml",
    "datetime": "2019-05-05 08:44:23",
    "code": "002755"
  },
  {
    "title": "[奥赛康]ASK爱奉献丨奥赛康药业积极参加义务献血活动",
    "href": "http://stock.jrj.com.cn/2019/05/05000031561827.shtml",
    "datetime": "2019-05-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "重组后首份成绩单：奥赛康去年实现净利润6.7亿元",
    "href": "http://stock.jrj.com.cn/2019/04/30163727514841.shtml",
    "datetime": "2019-04-30 16:37:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]《南京日报》专题报道奥赛康党建工作:让党建成为民企发展的“指南针”",
    "href": "http://stock.jrj.com.cn/2019/04/20000031561797.shtml",
    "datetime": "2019-04-20 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]爱奉献∣奥赛康药业义务参加植树活动",
    "href": "http://stock.jrj.com.cn/2019/03/13000031561796.shtml",
    "datetime": "2019-03-13 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业正式登陆资本市场",
    "href": "http://stock.jrj.com.cn/2019/03/12000031561794.shtml",
    "datetime": "2019-03-12 00:00:00",
    "code": "002755"
  },
  {
    "title": "重组上市完成 东方新星更名奥赛康",
    "href": "http://stock.jrj.com.cn/2019/03/11025527141865.shtml",
    "datetime": "2019-03-11 02:55:55",
    "code": "002755"
  },
  {
    "title": "东方新星11日起更名为“奥赛康”",
    "href": "http://stock.jrj.com.cn/2019/03/10175427141349.shtml",
    "datetime": "2019-03-10 17:54:57",
    "code": "002755"
  },
  {
    "title": "东方新星：证券简称3月11日起变更为“奥赛康”",
    "href": "http://stock.jrj.com.cn/2019/03/10163327141259.shtml",
    "datetime": "2019-03-10 16:33:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]亮剑精神∣奥赛康药业举办第十四届拔河比赛",
    "href": "http://stock.jrj.com.cn/2019/02/25000031561795.shtml",
    "datetime": "2019-02-25 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]南京市委组织部一行调研指导奥赛康人才与党建工作",
    "href": "http://stock.jrj.com.cn/2019/02/20000031561793.shtml",
    "datetime": "2019-02-20 00:00:00",
    "code": "002755"
  },
  {
    "title": "东方新星第五届董事会第一次会议 选举陈庆财任董事长 公司去年净利最高6.92亿元",
    "href": "http://stock.jrj.com.cn/2019/02/19154227062627.shtml",
    "datetime": "2019-02-19 15:42:19",
    "code": "002755"
  },
  {
    "title": "东方新星：拟更名为“奥赛康”",
    "href": "http://stock.jrj.com.cn/2019/01/23174126947803.shtml",
    "datetime": "2019-01-23 17:41:48",
    "code": "002755"
  },
  {
    "title": "东方新星预增60倍股价涨停 背后“推手”大曝光",
    "href": "http://stock.jrj.com.cn/2019/01/23164326947567.shtml",
    "datetime": "2019-01-23 16:43:55",
    "code": "002755"
  },
  {
    "title": "2018年盈利同比预增59至62倍 东方新星涨停",
    "href": "http://stock.jrj.com.cn/2019/01/22095026939887.shtml",
    "datetime": "2019-01-22 09:50:46",
    "code": "002755"
  },
  {
    "title": "东方新星：大幅上修2018年度业绩预告",
    "href": "http://stock.jrj.com.cn/hotstock/2019/01/22080026939333.shtml",
    "datetime": "2019-01-22 08:00:17",
    "code": "002755"
  },
  {
    "title": "东方新星：2018年年度业绩报告预告(修正公告)",
    "href": "http://stock.jrj.com.cn/2019/01/21220026937622.shtml",
    "datetime": "2019-01-21 22:00:06",
    "code": "002755"
  },
  {
    "title": "[奥赛康]2019年 奥赛康药业创新力再奏凯歌!",
    "href": "http://stock.jrj.com.cn/2019/01/03000031561792.shtml",
    "datetime": "2019-01-03 00:00:00",
    "code": "002755"
  },
  {
    "title": "东方新星：重组事项获无条件通过 30日起复牌",
    "href": "http://stock.jrj.com.cn/2018/11/29182325421958.shtml",
    "datetime": "2018-11-29 18:23:23",
    "code": "002755"
  },
  {
    "title": "东方新星：股票复牌的公告",
    "href": "http://stock.jrj.com.cn/2018/11/29174025421732.shtml",
    "datetime": "2018-11-29 17:40:00",
    "code": "002755"
  },
  {
    "title": "东方新星：并购重组事项将上会 29日起停牌",
    "href": "http://stock.jrj.com.cn/2018/11/28212925417956.shtml",
    "datetime": "2018-11-28 21:29:05",
    "code": "002755"
  },
  {
    "title": "东方新星：停牌公告",
    "href": "http://stock.jrj.com.cn/2018/11/28201025417818.shtml",
    "datetime": "2018-11-28 20:10:00",
    "code": "002755"
  },
  {
    "title": "证监会：立昂技术、东方新星重组事项11月29日上会",
    "href": "http://stock.jrj.com.cn/2018/11/23191325399079.shtml",
    "datetime": "2018-11-23 19:13:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]中国质量奖提名奖将奥赛康管理模式带上新高度",
    "href": "http://stock.jrj.com.cn/2018/11/05000031561789.shtml",
    "datetime": "2018-11-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "东方新星：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/30232025281726.shtml",
    "datetime": "2018-10-30 23:20:00",
    "code": "002755"
  },
  {
    "title": "东方新星：三季度新签岩土工程订单5935万元",
    "href": "http://stock.jrj.com.cn/2018/10/16164525210652.shtml",
    "datetime": "2018-10-16 16:45:00",
    "code": "002755"
  },
  {
    "title": "东方新星转型医药行业 三年期业绩承诺超20亿",
    "href": "http://stock.jrj.com.cn/2018/08/27100025003919.shtml",
    "datetime": "2018-08-27 10:00:00",
    "code": "002755"
  },
  {
    "title": "8月以来295只个股逆市上涨 强势股扎堆化工等三行业",
    "href": "http://stock.jrj.com.cn/2018/08/20000524971300.shtml",
    "datetime": "2018-08-20 00:05:21",
    "code": "002755"
  },
  {
    "title": "东方新星结束自查17日复牌 资金看好奥赛康借壳连续推高股价",
    "href": "http://stock.jrj.com.cn/2018/08/16210424963206.shtml",
    "datetime": "2018-08-16 21:04:00",
    "code": "002755"
  },
  {
    "title": "东方新星：股票交易异常波动核查结果暨复牌公告",
    "href": "http://stock.jrj.com.cn/2018/08/16174024962531.shtml",
    "datetime": "2018-08-16 17:40:00",
    "code": "002755"
  },
  {
    "title": "东方新星：自查工作完成 明日复牌",
    "href": "http://stock.jrj.com.cn/2018/08/16170024962356.shtml",
    "datetime": "2018-08-16 17:00:00",
    "code": "002755"
  },
  {
    "title": "东方新星：相关自查工作已经完成 17日起复牌",
    "href": "http://stock.jrj.com.cn/2018/08/16165124962306.shtml",
    "datetime": "2018-08-16 16:51:58",
    "code": "002755"
  },
  {
    "title": "A股头条：东方新星8连板遭特停 黄晓明深夜发声明",
    "href": "http://stock.jrj.com.cn/2018/08/15055324952229.shtml",
    "datetime": "2018-08-15 05:53:46",
    "code": "002755"
  },
  {
    "title": "东方新星：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/08/14214024951595.shtml",
    "datetime": "2018-08-14 21:40:00",
    "code": "002755"
  },
  {
    "title": "东方新星：股价异常波动暨停牌核查公告",
    "href": "http://stock.jrj.com.cn/2018/08/14205024951378.shtml",
    "datetime": "2018-08-14 20:50:00",
    "code": "002755"
  },
  {
    "title": "机构龙虎榜:5G概念股获关注 1机构买宜通世纪2264万",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/14203324951336.shtml",
    "datetime": "2018-08-14 20:33:10",
    "code": "002755"
  },
  {
    "title": "东方新星股价异动 15日起停牌核查",
    "href": "http://stock.jrj.com.cn/2018/08/14183824950937.shtml",
    "datetime": "2018-08-14 18:38:32",
    "code": "002755"
  },
  {
    "title": "东方新星继续8涨停：明日起停牌核查",
    "href": "http://stock.jrj.com.cn/2018/08/14183024950910.shtml",
    "datetime": "2018-08-14 18:30:00",
    "code": "002755"
  },
  {
    "title": "东方新星上半年净利润同比增长224%",
    "href": "http://stock.jrj.com.cn/2018/08/14182724950913.shtml",
    "datetime": "2018-08-14 18:27:47",
    "code": "002755"
  },
  {
    "title": "东方新星：股票连续8个交易日涨停 15日起停牌核查",
    "href": "http://stock.jrj.com.cn/2018/08/14182324950882.shtml",
    "datetime": "2018-08-14 18:23:42",
    "code": "002755"
  },
  {
    "title": "东方新星：股票连续8个交易日涨停 停牌核查",
    "href": "http://stock.jrj.com.cn/2018/08/14182124950873.shtml",
    "datetime": "2018-08-14 18:21:37",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续8日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/14093024948503.shtml",
    "datetime": "2018-08-14 09:30:16",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续7日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/13093324943455.shtml",
    "datetime": "2018-08-13 09:33:53",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续6日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/10132324937393.shtml",
    "datetime": "2018-08-10 13:23:36",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续5日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/09093124929332.shtml",
    "datetime": "2018-08-09 09:31:35",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续四日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/08093124922899.shtml",
    "datetime": "2018-08-08 09:31:06",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续三日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/07100324916005.shtml",
    "datetime": "2018-08-07 10:03:27",
    "code": "002755"
  },
  {
    "title": "工程建设板块上扬 东方新星涨停",
    "href": "http://stock.jrj.com.cn/2018/08/06100324909718.shtml",
    "datetime": "2018-08-06 10:03:37",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星连续两日涨停",
    "href": "http://stock.jrj.com.cn/2018/08/06100224909712.shtml",
    "datetime": "2018-08-06 10:02:52",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业七度入围中国医药工业信息中心颁发的“中国医药工业百强企业”榜",
    "href": "http://stock.jrj.com.cn/2018/08/05000031561790.shtml",
    "datetime": "2018-08-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业连续九年蝉联中国医药工业信息中心颁发的“中国医药研发产品线最佳工业企业”",
    "href": "http://stock.jrj.com.cn/2018/08/05000031561788.shtml",
    "datetime": "2018-08-05 00:00:00",
    "code": "002755"
  },
  {
    "title": "拟80亿元收购奥赛康药业 东方新星复牌涨停",
    "href": "http://stock.jrj.com.cn/2018/08/03093624900821.shtml",
    "datetime": "2018-08-03 09:36:45",
    "code": "002755"
  },
  {
    "title": "东方新星拟80亿元收购奥赛康药业 3日起复牌",
    "href": "http://stock.jrj.com.cn/2018/08/02215524897464.shtml",
    "datetime": "2018-08-02 21:55:09",
    "code": "002755"
  },
  {
    "title": "东方新星：关于公司股票复牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/08/02204024897259.shtml",
    "datetime": "2018-08-02 20:40:00",
    "code": "002755"
  },
  {
    "title": "东方新星半个月火速卖壳 奥赛康药业时隔6年拟上市",
    "href": "http://stock.jrj.com.cn/2018/07/23000524847318.shtml",
    "datetime": "2018-07-23 00:05:26",
    "code": "002755"
  },
  {
    "title": "东方新星谋求向医药制造领域转型",
    "href": "http://stock.jrj.com.cn/2018/07/21040024845129.shtml",
    "datetime": "2018-07-21 04:00:26",
    "code": "002755"
  },
  {
    "title": "投服中心对东方新星重组标的业绩提出三点疑问",
    "href": "http://stock.jrj.com.cn/2018/07/20182424843976.shtml",
    "datetime": "2018-07-20 18:24:00",
    "code": "002755"
  },
  {
    "title": "东方新星重组说明会：奥赛康十余个抗肿瘤药在研",
    "href": "http://stock.jrj.com.cn/2018/07/20171124843700.shtml",
    "datetime": "2018-07-20 17:11:00",
    "code": "002755"
  },
  {
    "title": "奥赛康药业欲借壳东方新星 作价80亿",
    "href": "http://stock.jrj.com.cn/2018/07/16035524817819.shtml",
    "datetime": "2018-07-16 03:55:56",
    "code": "002755"
  },
  {
    "title": "上市三年期满卖壳离场：东方新星亲身演绎“壳闹剧”",
    "href": "http://stock.jrj.com.cn/2018/07/12192324806940.shtml",
    "datetime": "2018-07-12 19:23:33",
    "code": "002755"
  },
  {
    "title": "奥赛康拟“借壳”东方新星",
    "href": "http://stock.jrj.com.cn/2018/07/11020324797118.shtml",
    "datetime": "2018-07-11 02:03:54",
    "code": "002755"
  },
  {
    "title": "奥赛康作价80亿元 欲借壳东方新星登陆A股",
    "href": "http://stock.jrj.com.cn/2018/07/10092124793519.shtml",
    "datetime": "2018-07-10 09:21:00",
    "code": "002755"
  },
  {
    "title": "东方新星：奥赛康药业拟作价80亿元借壳上市",
    "href": "http://stock.jrj.com.cn/2018/07/10083524793274.shtml",
    "datetime": "2018-07-10 08:35:00",
    "code": "002755"
  },
  {
    "title": "早间公告集锦：奥赛康药业将借壳上市",
    "href": "http://stock.jrj.com.cn/2018/07/10082324793244.shtml",
    "datetime": "2018-07-10 08:23:15",
    "code": "002755"
  },
  {
    "title": "东方新星披露重大资产重组方案 奥赛康药业拟借壳",
    "href": "http://stock.jrj.com.cn/2018/07/10081924793212.shtml",
    "datetime": "2018-07-10 08:19:47",
    "code": "002755"
  },
  {
    "title": "东方新星：董事会审议重大资产重组事项 9日起停牌",
    "href": "http://stock.jrj.com.cn/2018/07/06221424782165.shtml",
    "datetime": "2018-07-06 22:14:45",
    "code": "002755"
  },
  {
    "title": "东方新星：关于董事会审议重大资产重组事项及公司股票停牌的公告",
    "href": "http://stock.jrj.com.cn/2018/07/06212024782026.shtml",
    "datetime": "2018-07-06 21:20:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]南京市委副书记、市长蓝绍敏莅临奥赛康药业参观调研",
    "href": "http://stock.jrj.com.cn/2018/06/23000031561806.shtml",
    "datetime": "2018-06-23 00:00:00",
    "code": "002755"
  },
  {
    "title": "大通燃气：未来不会再推进收购奥赛康药业",
    "href": "http://stock.jrj.com.cn/2018/06/12111324668371.shtml",
    "datetime": "2018-06-12 11:13:00",
    "code": "002755"
  },
  {
    "title": "大通燃气：终止重组收购奥赛康药业 明起复牌",
    "href": "http://stock.jrj.com.cn/2018/06/10163524659932.shtml",
    "datetime": "2018-06-10 16:35:00",
    "code": "002755"
  },
  {
    "title": "东方新星股权变动引深交所发关注函",
    "href": "http://stock.jrj.com.cn/2018/05/16064824544970.shtml",
    "datetime": "2018-05-16 06:48:25",
    "code": "002755"
  },
  {
    "title": "解除协议为减持铺路？ 东方新星大股东与一致行动人不再续签",
    "href": "http://stock.jrj.com.cn/2018/05/15235424544394.shtml",
    "datetime": "2018-05-15 23:54:37",
    "code": "002755"
  },
  {
    "title": "东方新星股权结构分散引深交所发函关注",
    "href": "http://stock.jrj.com.cn/2018/05/15153024542298.shtml",
    "datetime": "2018-05-15 15:30:00",
    "code": "002755"
  },
  {
    "title": "东方新星：实控人一致行动协议到期未“续签” 股权结构分散",
    "href": "http://stock.jrj.com.cn/2018/05/14202324537710.shtml",
    "datetime": "2018-05-14 20:23:00",
    "code": "002755"
  },
  {
    "title": "东方新星实控人一致行动协议到期 公司股权结构分散",
    "href": "http://stock.jrj.com.cn/2018/05/14200324537588.shtml",
    "datetime": "2018-05-14 20:03:17",
    "code": "002755"
  },
  {
    "title": "东方新星：实控人一致行动协议到期 股权结构分散",
    "href": "http://stock.jrj.com.cn/2018/05/14192524537438.shtml",
    "datetime": "2018-05-14 19:25:00",
    "code": "002755"
  },
  {
    "title": "公司2017年业绩上涨超一倍 东方新星强势涨停",
    "href": "http://stock.jrj.com.cn/2018/04/25131924448917.shtml",
    "datetime": "2018-04-25 13:19:11",
    "code": "002755"
  },
  {
    "title": "东方新星：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/24232024443277.shtml",
    "datetime": "2018-04-24 23:20:00",
    "code": "002755"
  },
  {
    "title": "东方新星：2017年净利增长138% 拟10转7派0.35元",
    "href": "http://stock.jrj.com.cn/2018/04/24223524443195.shtml",
    "datetime": "2018-04-24 22:35:00",
    "code": "002755"
  },
  {
    "title": "东方新星一季度预盈200万元-500万元",
    "href": "http://stock.jrj.com.cn/2018/03/28165724315186.shtml",
    "datetime": "2018-03-28 16:57:20",
    "code": "002755"
  },
  {
    "title": "东方新星：一季度净利预计同比扭亏",
    "href": "http://stock.jrj.com.cn/2018/03/28161524314880.shtml",
    "datetime": "2018-03-28 16:15:00",
    "code": "002755"
  },
  {
    "title": "准IPO公司成标的 大通燃气拟购奥赛康药业",
    "href": "http://stock.jrj.com.cn/ipo/2018/03/21085724270956.shtml",
    "datetime": "2018-03-21 08:57:00",
    "code": "002755"
  },
  {
    "title": "准IPO公司成并购标的 大通燃气拟收购奥赛康药业",
    "href": "http://stock.jrj.com.cn/2018/03/21041124269889.shtml",
    "datetime": "2018-03-21 04:11:02",
    "code": "002755"
  },
  {
    "title": "公告精选：中国平安2017年净利大增42.8%；大通燃气拟收购奥赛康药业",
    "href": "http://stock.jrj.com.cn/2018/03/20222524269271.shtml",
    "datetime": "2018-03-20 22:25:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]不忘初心,共谋高质量发展",
    "href": "http://stock.jrj.com.cn/2018/02/28000031561805.shtml",
    "datetime": "2018-02-28 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]深入学习十九大精神,为实现美好生活奋斗!",
    "href": "http://stock.jrj.com.cn/2017/12/14000031561802.shtml",
    "datetime": "2017-12-14 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业荣获“国家知识产权示范企业”称号",
    "href": "http://stock.jrj.com.cn/2017/12/01000031561803.shtml",
    "datetime": "2017-12-01 00:00:00",
    "code": "002755"
  },
  {
    "title": "东方新星：2017年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2017/08/17202022955912.shtml",
    "datetime": "2017-08-17 20:20:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]继续从“新”出发——公司董事长荣获 “2016-2017年度苏商富民强省新领军者”",
    "href": "http://stock.jrj.com.cn/2017/08/09000031561800.shtml",
    "datetime": "2017-08-09 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康药业成立公司红十字会",
    "href": "http://stock.jrj.com.cn/2017/07/19000031561801.shtml",
    "datetime": "2017-07-19 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]奥赛康PPI产品专利以评比总分第一的成绩荣获江苏省专利金奖",
    "href": "http://stock.jrj.com.cn/2017/06/09000031561799.shtml",
    "datetime": "2017-06-09 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]用“企业家精神”驱动医药细分领域发展",
    "href": "http://stock.jrj.com.cn/2017/02/20000031561787.shtml",
    "datetime": "2017-02-20 00:00:00",
    "code": "002755"
  },
  {
    "title": "[奥赛康]公司隆重举办检测中心大楼奠基仪式",
    "href": "http://stock.jrj.com.cn/2017/01/07000031561839.shtml",
    "datetime": "2017-01-07 00:00:00",
    "code": "002755"
  },
  {
    "title": "[互动]东方新星中标郑州地铁勘察项目",
    "href": "http://stock.jrj.com.cn/2016/10/19140221590853.shtml",
    "datetime": "2016-10-19 14:02:47",
    "code": "002755"
  },
  {
    "title": "东方新星收到上市奖励专项资金300万元",
    "href": "http://stock.jrj.com.cn/2016/10/17155521580035.shtml",
    "datetime": "2016-10-17 15:55:57",
    "code": "002755"
  },
  {
    "title": "龙虎榜:瑞鹤仙两扳森远股份与赵老哥比肩 温州庄被玩",
    "href": "http://stock.jrj.com.cn/hotstock/2016/09/23230021519070.shtml",
    "datetime": "2016-09-23 23:00:15",
    "code": "002755"
  },
  {
    "title": "东方新星近期股价异动 7日起停牌核查",
    "href": "http://stock.jrj.com.cn/2016/09/06200121424013.shtml",
    "datetime": "2016-09-06 20:01:19",
    "code": "002755"
  },
  {
    "title": "东方新星：拟出资100万文莱元设立文莱子公司",
    "href": "http://stock.jrj.com.cn/hotstock/2016/01/22080020464182.shtml",
    "datetime": "2016-01-22 08:00:01",
    "code": "002755"
  },
  {
    "title": "东方新星：拟设立重庆分公司",
    "href": "http://stock.jrj.com.cn/hotstock/2015/11/20075920105721.shtml",
    "datetime": "2015-11-20 07:59:56",
    "code": "002755"
  },
  {
    "title": "小学老师借IPO上演暴富神话：3年获57倍暴利",
    "href": "http://stock.jrj.com.cn/ipo/2014/03/14100816866333.shtml",
    "datetime": "2014-03-14 10:08:16",
    "code": "002755"
  },
  {
    "title": "慈铭体检被指另一个奥赛康 老股套现或达新股募资9倍",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/20111216536665.shtml",
    "datetime": "2014-01-20 11:12:17",
    "code": "002755"
  },
  {
    "title": "奥赛康“32亿家族式套现”刹车",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/20071116534036.shtml",
    "datetime": "2014-01-20 07:11:42",
    "code": "002755"
  },
  {
    "title": "IPO公司红黑榜 奥赛康们的利益链条",
    "href": "http://stock.jrj.com.cn/ipo/2014/01/18153316532506.shtml",
    "datetime": "2014-01-18 15:33:25",
    "code": "002755"
  }
]